Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 TrialNigel H Russell, Abin Thomas, Robert K Hills, et al.Blood|August 6, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AMLJad Othman, Nicola Potter, Sylvie D Freeman, et al.The Lancet. Haematology|April 30, 2025
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trialsNicola Potter, Jelena Jovanovic, Adam Ivey, et al.Blood|August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trialSylvie D Freeman, Abin Thomas, Ian Thomas, et al.Pharmacotherapy|June 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical PharmacyDavid B Cluck, Daniel B Chastain, Milena Murray, et al.Pharmacotherapy|June 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summaryDavid B Cluck, Daniel B Chastain, Milena Murray, et al.Transplantation Direct|September 13, 2021
Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 PandemicMatthew J Weiss, Laura Hornby, Farid Foroutan, et al.Journal of Cardiothoracic Surgery|November 4, 2021
PROSE: Prospective Randomized Trial of the On-X Mechanical Prosthesis and the St Jude Medical Mechanical Prosthesis Evaluation : Part 1(Patient Dynamics): Preoperative demographics and preoperative and operative risk factorsW R Eric Jamieson, John L Ely, Johan Brink, et al.JTCVS Open|January 2, 2023
PROSE: Prospective Randomized Trial of the On-X Mechanical Prosthesis and the St Jude Medical Mechanical Prosthesis Evaluation: Part 2: Study results-prostheses, positions, and economic developmentW R Eric Jamieson, John L Ely, Johan Brink, et al.Blood|May 1, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AMLJad Othman, Nicola Potter, Adam Ivey, et al.Pageof 16